A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.

(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene

CAS135821-74-8

List details

Basic info

Status Intention
Details on the scope of restriction The proposal intends to restrict the manufacture, use and placing on the market of Dechlorane Plus™ as substances, constituents of other substances, mixtures and articles or parts thereof.
Further substance information Non-exhaustive list of relevant numerical identifiers for the Candidate List entry “1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”TM) [covering any of its individual antiand syn- isomers or any combination thereof]”, see: https://echa.europa.eu/documents/10162/9aa77dde-f0fc-4422-2c00-55b620e57552
Reason for restriction Dechlorane Plus is a substance of very high concern due to its very persistent and very bioaccumulating properties. The substance is widely detected in the global environment and some studies indicate increasing concentrations. Dechlorane plus has also been detected in human blood, placenta and breast milk. Norway has submitted a proposal to list Dechlorane Plus and its syn- and anti-isomers in Annexes A, B and/or C to the Stockholm Convention on Persistent Organic Pollutants.

Intention timeline

Date of intention 2020-08-26
Expected date of submission 2021-04-09
Latest update 2020-10-01

Support information

Related substances

No substances related to this record were found in our database.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

Oct. 14, 2020
  • Latest update: 2020-10-012020-10-14
  • Remarks: Stakeholders are requested to provide any information relevant to the Dossier Submitter during the Annex XV Restriction Dossier process, either in any call for evidence or separately during the process. This information will be used, amongst other issues, to determine if any derogations are required for the potential restriction as these cannot be proposed without adequate risk and socio-economic information. If a derogation is not proposed by the Dossier Submitter then it will be incumbent on the relevant stakeholders to do so during any consultation process with a full risk and socio-economic justification accompanying it.
This version
Oct. 2, 2020
  • Details on the scope of restriction: The proposal intends to restrict the manufacture, use and placing on the market of 1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”™) [covering any of its individual anti- and synisomers or any combination thereof] as substances, constituents of other substances, mixtures and articles or parts thereof.The proposal intends to restrict the manufacture, use and placing on the market of Dechlorane Plus™ as substances, constituents of other substances, mixtures and articles or parts thereof.
  • Latest update: 2020-09-022020-10-01
  • Reason for restriction: Dechlorane plus is a substance of very high concern due to its very persistent and very bioaccumulating properties. The substance is widely detected in the global environment and some studies indicate increasing concentrations. Dechloran plus has also been detected in human blood, placenta and breast milk. Norway has submitted a proposal to list Dechlorane Plus and its syn- and anti-isomers in Annexes A, B and/or C to the Stockholm Convention on Persistent Organic Pollutants.Dechlorane Plus is a substance of very high concern due to its very persistent and very bioaccumulating properties. The substance is widely detected in the global environment and some studies indicate increasing concentrations. Dechlorane plus has also been detected in human blood, placenta and breast milk. Norway has submitted a proposal to list Dechlorane Plus and its syn- and anti-isomers in Annexes A, B and/or C to the Stockholm Convention on Persistent Organic Pollutants.
Sept. 30, 2020
  • Name: 1,4:7,10-Dimethanodibenzo[a,e]cyclooctene, 1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro-, (1R,4S,4aS,6aS,7S,10R,10aR,12aR)-rel-(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene